MED12 mutations have been identified in uterine fibroids among women from diverse ethnic backgrounds—including North American, European, African, Asian, and Middle Eastern populations—highlighting its role as a major driver in leiomyoma pathogenesis [84,85]. The gene discussed is MED12; the disease is leiomyoma.